Cargando…
Experimental Schistosoma japonicum-induced pulmonary hypertension
BACKGROUND: Schistosomiasis, a major cause of pulmonary arterial hypertension (PAH) worldwide, is most clearly described complicating infection by one species, Schistosoma mansoni. Controlled exposure of mice can be used to induce Type 2 inflammation-dependent S. mansoni pulmonary hypertension (PH)....
Autores principales: | Kassa, Biruk, Lee, Michael H., Kumar, Rahul, Mickael, Claudia, Sanders, Linda, Tuder, Rubin M., Mentink-Kane, Margaret, Graham, Brian B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037943/ https://www.ncbi.nlm.nih.gov/pubmed/35417453 http://dx.doi.org/10.1371/journal.pntd.0010343 |
Ejemplares similares
-
Paclitaxel blocks Th2-mediated TGF-β activation in
Schistosoma mansoni-induced pulmonary
hypertension
por: Kassa, Biruk, et al.
Publicado: (2018) -
Repetitive schistosoma exposure causes perivascular lung fibrosis and persistent pulmonary hypertension
por: Kumar, Rahul, et al.
Publicado: (2023) -
Th2 CD4(+) T Cells Are Necessary and Sufficient for Schistosoma‐Pulmonary Hypertension
por: Kumar, Rahul, et al.
Publicado: (2019) -
The role of macrophages in right ventricular remodeling in experimental pulmonary hypertension
por: Gu, Sue, et al.
Publicado: (2022) -
Stable isotope metabolomics of pulmonary artery smooth muscle and endothelial cells in pulmonary hypertension and with TGF-beta treatment
por: Hernandez-Saavedra, Daniel, et al.
Publicado: (2020)